Ad is loading...
JAIGX
Price
$43.91
Change
-$0.43 (-0.97%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

JAIGX vs VTSNX

Header iconJAIGX vs VTSNX Comparison
Open Charts JAIGX vs VTSNXBanner chart's image
Janus Henderson VIT Overseas Instl
Price$43.91
Change-$0.43 (-0.97%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
JAIGX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JAIGX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAIGX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. JAIGX (673M). VTSNX pays higher dividends than JAIGX: VTSNX (3.29) vs JAIGX (1.37). JAIGX was incepted earlier than VTSNX: JAIGX (31 years) vs VTSNX (14 years). JAIGX is a more actively managed with annual turnover of: 30.00 vs. VTSNX (4.00). JAIGX has a lower initial minimum investment than VTSNX: JAIGX (0) vs VTSNX (5000000). JAIGX annual gain was more profitable for investors over the last year : 11.80 vs. VTSNX (10.92). JAIGX return over 5 years is better than : 48.34 vs. VTSNX (15.91).
JAIGXVTSNXJAIGX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years14 years-
Gain YTD4.8784.535108%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets673M442B0%
Annual Yield % from dividends1.373.2942%
Returns for 1 year11.8010.92108%
Returns for 3 years5.06-5.86-86%
Returns for 5 years48.3415.91304%
Returns for 10 years48.7529.81164%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals